⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 14, 2010Cancer

Comparison of intensity‐modulated radiotherapy and 3‐dimensional conformal radiotherapy as adjuvant therapy for gastric cancer

A. Yuriko Minn Annie Hsu Trang H. La Pamela L. Kunz George A. Fisher James M. Ford Jeffrey A. Norton Brendan C. Visser Karyn A. Goodman Albert C. Koong Daniel T. Chang

View at Publisher

Ask AI

Bookmark

Share

Abstract

Adjuvant chemoradiotherapy was well tolerated. IMRT was found to provide sparing to the liver and possibly renal function.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Minn et al. (2010) studied this question.

synapsesocial.com/papers/69d8c14f537c710c9cae2b74 https://doi.org/10.1002/cncr.25246

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Cancer Statistics, 2009Registry Study · 2009 · 9,712 citations
2Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal JunctionOriginal Research · 2001 · 3,477 citations
3Intensity-modulated radiation therapy in the treatment of gastric cancer: early clinical outcome and dosimetric comparison with conventional techniquesOriginal Research · 2006 · 92 citations
4Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapyPrognostic Study · 2006 · 1,930 citations
5Body mass index at diagnosis, postdiagnosis change, and role of metabolic comorbidities in relation to survival in nonmetastatic renal cell carcinoma patientsCancer · Fri,

More from Cancer

Generative artificial intelligence in medical oncology: A clinically focused narrative review of large language, vision‐language, and agentic artificial intelligence systemsFri,
Risk factors and outcome of children and young adults with initially unresected nonrhabdomyosarcoma soft tissue sarcoma: An analysis from the International Soft Tissue Sarcoma ConsortiumThu,
Cancer risks associated with BRCA1 and BRCA2 : Overview and managementWed,
Real‐world outcomes in circulating tumor DNA–detected isocitrate dehydrogenase 1–mutant cholangiocarcinoma: First‐line gemcitabine and cisplatin with versus without immunotherapyWed,
Increased risk of stroke after a new cancer diagnosis—Where are the knowledge gaps currently?Tue,